Hjem › KOL › Indiana › Indianapolis
KOL kliniske forsøg i Indianapolis, IN
6 studier for KOL søger deltagere på steder i og omkring Indianapolis (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RekruttererFase 2
- DM Clinical Research-Indianapolis, Indianapolis
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
- Indiana University Health University Hospital, Indianapolis
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- Indy Clinical Research- Site Number : 8400071, Indianapolis
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RekruttererFase 3
- Research Site, Indianapolis
- Research Site, Indianapolis
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
RekruttererObservationsstudie
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
Acoustic Waveform Respiratory Evaluation
RekruttererFrivillige med god helbredstilstand velkomne
- Indiana University, Indianapolis
KOL forsøg i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Houston, TX15 studier
- Orlando, FL15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
Andre studier i Indianapolis
- Ikke-småcellet lungecancer32 studier
- Kræft (alle typer)24 studier
- Hjertesvigt23 studier
- Brystkræft20 studier
- Overvægt20 studier
- Metastatisk cancer19 studier
- Colorektal kræft18 studier
- Ægstockræft17 studier
- Lungecancer16 studier
- Kardiovaskulær sygdom16 studier
- Type 1-diabetes14 studier
- Livmoderslimhindekræft14 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.